Ropes & Gray Advises Zai Lab on $200 Million Secondary Offering
November 21, 2024
November 21, 2024
BOSTON, Massachusetts, Nov. 21 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray represented Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) in its $200 million secondary offering. The transaction closed on Nov. 18.
Zai Lab is a commercial-stage biopharmaceutical company based in China and the United States. The company is focused on discovering, developing, and commercializing innovative products in the areas of oncology, immunology, neuroscience an . . .
Ropes & Gray represented Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) in its $200 million secondary offering. The transaction closed on Nov. 18.
Zai Lab is a commercial-stage biopharmaceutical company based in China and the United States. The company is focused on discovering, developing, and commercializing innovative products in the areas of oncology, immunology, neuroscience an . . .